These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31801586)

  • 1. Correction to: Viral integration drives multifocal HCC during the occult HBV infection.
    Chen XP; Long X; Jia WL; Wu HJ; Zhao J; Liang HF; Laurence A; Zhu J; Dong D; Chen Y; Lin L; Xia YD; Li WY; Li GB; Zhao ZK; Wu K; Hou Y; Yu JJ; Xiao W; Wang GP; Zhu PC; Chen W; Bai MZ; Jian YX; Kristiansen K; Chen Q
    J Exp Clin Cancer Res; 2019 Dec; 38(1):480. PubMed ID: 31801586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.
    Saitta C; Tripodi G; Barbera A; Bertuccio A; Smedile A; Ciancio A; Raffa G; Sangiovanni A; Navarra G; Raimondo G; Pollicino T
    Liver Int; 2015 Oct; 35(10):2311-7. PubMed ID: 25677098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.
    Pollicino T; Squadrito G; Cerenzia G; Cacciola I; Raffa G; Craxi A; Farinati F; Missale G; Smedile A; Tiribelli C; Villa E; Raimondo G
    Gastroenterology; 2004 Jan; 126(1):102-10. PubMed ID: 14699492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Occult hepatitis B virus infection and hepatocellular carcinoma].
    Lee JJ; Kwon OS
    Korean J Gastroenterol; 2013 Sep; 62(3):160-4. PubMed ID: 24077626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction to: The evolutionary genetics of lactase persistence in seven ethnic groups across the Iranian plateau.
    Charati H; Peng MS; Chen W; Yang XY; Ori RJ; Aghajanpour-Mir M; Esmailizadeh A; Zhang YP
    Hum Genomics; 2019 Mar; 13(1):16. PubMed ID: 30902111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
    Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis.
    Shi Y; Wu YH; Wu W; Zhang WJ; Yang J; Chen Z
    Liver Int; 2012 Feb; 32(2):231-40. PubMed ID: 21745272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.
    Wong DK; Huang FY; Lai CL; Poon RT; Seto WK; Fung J; Hung IF; Yuen MF
    Hepatology; 2011 Sep; 54(3):829-36. PubMed ID: 21809355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M
    Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
    Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M
    J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
    Ringelhan M; Heikenwalder M; Protzer U
    Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.
    Fang Y; Shang QL; Liu JY; Li D; Xu WZ; Teng X; Zhao HW; Fu LJ; Zhang FM; Gu HX
    J Infect; 2009 May; 58(5):383-8. PubMed ID: 19329189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of occult HBV infections.
    Chemin I; Trépo C
    J Clin Virol; 2005 Dec; 34 Suppl 1():S15-21. PubMed ID: 16461218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.
    Kusakabe A; Tanaka Y; Orito E; Sugauchi F; Kurbanov F; Sakamoto T; Shinkai N; Hirashima N; Hasegawa I; Ohno T; Ueda R; Mizokami M
    J Gastroenterol; 2007 Apr; 42(4):298-305. PubMed ID: 17464459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
    Hutcheson IR; Knowlden JM; Hiscox SE; Barrow D; Gee JMW; Robertson JF; Ellis IO; Nicholson RI
    Breast Cancer Res; 2018 Aug; 20(1):98. PubMed ID: 30165904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
    Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction to: Metacognitive therapy vs. eye movement desensitization and reprocessing for posttraumatic stress disorder: study protocol for a randomized superiority trial.
    Nordahl HM; Halvorsen JØ; Hjemdal O; Ternava MR; Wells A
    Trials; 2018 Mar; 19(1):164. PubMed ID: 29510757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study.
    Sagnelli E; Imparato M; Coppola N; Pisapia R; Sagnelli C; Messina V; Piai G; Stanzione M; Bruno M; Moggio G; Caprio N; Pasquale G; Del Vecchio Blanco C
    J Med Virol; 2008 Sep; 80(9):1547-53. PubMed ID: 18649338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.
    Yan H; Yang Y; Zhang L; Tang G; Wang Y; Xue G; Zhou W; Sun S
    Hepatology; 2015 Jun; 61(6):1821-31. PubMed ID: 25627239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.